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Abstract
Background: A genetic study was performed to identify candidate genes associated with day
blindness in the standard wire haired dachshund. Based on a literature review of diseases in dogs
and human with phenotypes similar to day blindness, ten genes were selected and evaluated as
potential candidate genes associated with day blindness in the breed.
Results: Three of the genes, CNGB3, CNGA3 and GNAT2, involved in cone degeneration and seven
genes and loci, ABCA4, RDH5, CORD8, CORD9, RPGRIP1, GUCY2D and CRX, reported to be involved
in cone-rod dystrophies were studied. Polymorphic markers at each of the candidate loci were
studied in a family with 36 informative offspring. The study revealed a high frequency of
recombinations between the candidate marker alleles and the disease.
Conclusion: Since all of the markers were at the exact position of the candidate loci, and several
recombinations were detected for each of the loci, all ten genes were excluded as causal for this
canine, early onset cone-rod dystrophy. The described markers may, however, be useful to screen
other canine resource families segregating eye diseases for association to the ten genes.
Background
Inherited retinal degenerations form a diverse spectrum of
blinding disorders in humans and other mammals,
including a large number of dog breeds [1]. Retinal dis-
eases are inherited as monogenic or complex traits. In the
last two decades over 130 genes that cause retinal diseases
have been identified [2].
Progressive retinal atrophies (PRA) are the most common
retinopathies in dogs and constitute a heterogeneous
group of phenotypically similar disorders equivalent to
retinitis pigmentosa (RP) in man. PRA, like RP, is prima-
rily a disease of rod photoreceptors, while cone function
and structure degenerate secondarily. PRA has been iden-
tified and studied in more than 100 breeds and distinct
loci primarily responsible for each disorder have been
identified in at least 22 different breeds [1,3].
The cone dystrophies comprise a phenotypically heteroge-
neous group of hereditary retinal degenerations character-
ized by progressive dysfunction of the photopic (cone-
mediated) system. The presenting signs include day blind-
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ness, loss of colour vision, reduced central visual acuity
and preserved peripheral vision [4]. The cone dystrophies
are genetically heterogenous and may be sporadic, auto-
somal dominant, autosomal recessive or X-linked reces-
sive [2].
Canine cone degeneration is phenotypically similar to
human achromatopsia [5]. Identified genes associated
with human achromatopsia are the phototransducin
genes GNAT2 (HSA1) [6], the CNGA3 (HSA2) [7] and the
CNGB3 (HSA8) [8] genes.
Autosomal recessive cone degeneration occurs naturally
in Alaskan malamute [9] and German shorthaired pointer
(GSP) and is due to different mutations in CNGB3 [5,10].
Sporadic cases is seen in a number of other breeds [11,12].
The cone-rod dystrophies (crd) are characterized by a pre-
dominant loss of cone function, with relative preservation
of rod function [13,14]. The number of genes or loci cur-
rently identified for crd in humans is low, compared to
those for RP [2]. Identified genes associated with auto-
somal recessive inherited crd in man include ABCA4
[15,16] and RDH5 [17] in addition to the mapped loci
CORD8 [18,19] and CORD9 [20]. ABCA4 and RDH5 are
genes involved in the retinoid cycle, the CORD8  and
CORD9 loci are yet to be identified. The standard wire
haired dachshund (SWHD), the miniature long haired
dachshund (MLHD) and the pit bull terrier (PBT) are the
only dog breeds to date known to be affected by crd [21-
23].
Canine ABCA4 has been studied as a candidate gene for
cone-rod degeneration in the pit bull terrier, although no
mutations were found [21]. Mutations in the RPGRIP1
gene have been reported to be a cause of Leber congenital
amaurosis (LCA) [24,25]. LCA is the earliest and most
severe form of all retinal dystrophies responsible for con-
genital blindness [26]. Mutations causing residual
RPGRIP1 activity may lead to phenotypes such as RP or
crd, which are less severe than LCA [27]. In 2003, Hameed
et al. (2003) [28] showed evidence that some RPGRIP1
gene mutations are associated with recessive cone-rod
dystrophy. Recently Mellersh et al. (2006) [22] found a
mutation in canine RPGRIP1 associated with autosomal
recessive crd in miniature longhaired dachshunds.
A high level of genetic heterogeneity of the disease group
is observed and a range of mutations in RPGRIP1, CRX
and GUCY2D cause different retinal diseases with differ-
ent modes of inheritance [14,27-34].
A resource strain of standard wire haired dachshund dis-
playing day blindness was developed to allow characteri-
zation of the phenotype and identification of the causal
mutation. Electroretinography (ERG) and clinical studies
showed that secondary degeneration of the rods appeared
during the progression of the disease of the dogs of the
colony, indicating a progressive cone-rod dystrophy (crd)
[23]. The disease seems to be inherited in an autosomal
recessive manner, and diversity in the age of onset and
progression of the retinal degeneration within the group
of affected dachshunds is observed.
This study was conducted in parallel with clinical studies
[35] and genes known to be involved in human cone
degeneration, cone dystrophy and cone-rod dystrophy
were evaluated as candidate genes for the day blindness in
the SWHD (See Table 1).
Results
An overview of the studied genes and their location is
shown in Table 1. Studies of segregation of each of the 10
candidate loci and clinical disease in informative parents
and offspring revealed a number of new candidate gene
allele-disease phenotype combinations ("recombinants")
in the offspring. The segregation of potential candidate
gene alleles was studied in inbred offspring from parents
Table 1: Overview of the candidate genes
Candidate Canine chr Location Annotation Coding for Disease*
CNGB3 CFA29 35896147-35752878 NC_006611 cyclic nucleotide gated channel beta 3 cd
CNGA3 CFA10 47377091-47357441 NC_006592 cyclic nucleotide gated channel alpha 3 cd
GNAT2 CFA6 45319301-45327681 NC_006588 guanine nucleotide binding protein (G protein), alpha 
transducing activity polypeptide 2
cd
ABCA4 CFA6 58112924-58240779 NC_006588 ATP-binding cassette, sub-family A (ABC1), member 4 crd
RDH5 CFA10 3102451-3106432 NC_006592 retinol dehydrogenase 5 (11-cis/9-cis) crd
CORD8 CFA9 HSA1q12–24 unknown crd
CORD9 CFA29 HSA8p11 unknown crd
RPGRIP1 CFA15 21355638-21394395 NC_006597 retinitis pigmentosa GTPase regulator interacting protein 1 crd
GUCY2D CFA5 35838279-35853509 NC_006587 guanylate cyclase 2D, membrane (retina-specific) crd
CRX CFA1 111135799-111146903 NC_006583 cone-rod homeobox crd
*cd = cone degeneration and crd = cone-rod-dystrophyBMC Veterinary Research 2008, 4:23 http://www.biomedcentral.com/1746-6148/4/23
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with known disease genotypes. Females where either
homozygous affected (= clinical diseased) or carriers (=
clinical healthy offspring of affected male). Since the
father in these litters usually was homozygous affected,
the theoretical phenotype of the offspring would depend
on which of the two potential alleles (affected or non-
affected) it received from its carrier mother. The most fre-
quently occurring genotype-phenotype combination was
counted as the non-recombinants, while any new geno-
type-phenotype combination, with regard to their par-
ents, was counted as recombinant. Each litter was counted
as a separate unit and the recombination frequency were
summed over all families. A minimum of 6 recombinants
were identified for each of the 10 loci (See Table 2). This
excludes all the candidate genes as the cause of mutation
causing the disease. The family is illustrated in Figure 1.
The genotypes of ABCA4-markers are shown below each
individual and show free recombination of ABCA4-vari-
ants between affected and unaffected offspring.
Discussion
The large number of retinal genes or loci have been iden-
tified and presented at the RetNet™ web page [2], facili-
tates a candidate gene approach in the study of canine
retinal diseases. Human genes with mutations giving sim-
ilar phenotypes and inheritance patterns to the one found
in the affected SWHDs were selected as candidate genes.
The preliminary clinical diagnoses for the affected SWHDs
suggested that the disease was comparable with human
cone degeneration, hence the inclusion of CNGB3,
CNGA3 and GNAT2, which are associated primarily with
cone degeneration. In the initial phase of the study the
family material was not sufficient for segregation studies
and we therefore sequenced the coding parts of these three
genes. No mutations where identified in any of the three
genes (methods and results not shown). Continued elec-
trophysiological and clinical studies of the affected dachs-
hunds were conducted in parallel with the genetic studies
and revealed secondary continuing degeneration of the
rods, indicating a progressive cone-rod dystrophy (crd)
[23]. Seven genes reported to be associated with auto-
somal recessive cone-rod dystrophies (crd) [2], ABCA4,
RDH5,  CORD8,  CORD9,  RPGRIP1,  CRX  and  GUCY2D
were therefore included in the study.
It is important to be aware of the fact that the disease-
allele/haplotype present in all dogs in the family arises
from inbreeding on one single affected founder (Figure
1). The informative markers were selected at the exact
position of the candidate genes, most of them less than
approximately 0.1 Mb distance. A distance of 0.1 Mb com-
pares to a genetic distance of ~0.1 cM, or 1 recombination
per 1000 offspring. The minimum number of detected
recombinations in our family (1 recombination per 36
informative offspring) would compare to a recombina-
tion frequency/genetic distance of ~2.8 cM or a physical
distance of ~2.8 Mb. We would not expect any recom-
binants if a mutation in any of the candidate genes caused
this disease with a simple recessive inheritance. Our
results show a minimum of 6 recombinations (GNAT2;
31 informative offspring) or more than 19.3 Mb distance
(Table 2), excluding all the candidate genes as the site of
the mutation causing the disease. However, even though
the specific candidate genes can be excluded as the cause
of the disease because of the high number of recombina-
tions, the chromosomal regions are not necessarily
excluded. The clinical findings defining the diseases as a
cone-rod dystrophy rather than cone degeneration also
support the exclusion of CNGB3, CNGA3 and GNAT2.
The candidate loci CORD8  and  CORD9  are not yet
mapped and the genes remain to be identified, but the
markers typed for these loci are located within 2.8 Mb of
the gene and several recombinations exclude these loci as
well.
It might be considered likely that crd in MLDH and
SWDH was caused by the same mutation, since these two
breeds have in part the same genetic background. There
are, however, obvious differences in the clinical pheno-
types of the disease in the two breeds. One of the most
characteristic clinical findings in the SWDH is pinpoint-
sized pupils, observed in 60% of the 8-week old, crd-
affected puppies. Older crd-affected dogs displayed
dilated pupils and delayed pupillary light reflexes (PLRs)
Table 2: Recombination frequencies between candidate gene loci (microsatellites at locus) and disease
Locus no. of informative offspring no. of recombinant offspring Recombination frequency LOD score
CNGB3 34 11 0.32 0.940
CNGA3 20 7 0.35 0.397
GNAT2 31 6 0.19 2.717
ABCA4 34 11 0.32 0.940
RDH5 34 11 0.32 0.940
CORD8 25 10 0.40 0.219
CORD9 18 5 0.28 0.800
CRX 24 8 0.33 0.590
GUCY2D 23 7 0.30 0.786BMC Veterinary Research 2008, 4:23 http://www.biomedcentral.com/1746-6148/4/23
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when stimulated with a focal light source [23]. This is in
contrast to the clinical signs of PBT and MLHD, which
include dilated pupils at 7–8 weeks of age for PBT and
normal PLRs at 25 weeks of age for MLHD, respectively
[21,34]. The differences in clinical signs between the
MLHD and the SWHD, support the finding of free recom-
bination between RPGRIP1 and the disease in the SWHD.
This shows that this disease in the SWHDs is a unique ani-
mal model for cone-rod dystrophy.
The development of animal models of ocular disease rep-
resents an invaluable resource for testing and evaluating
treatment strategies relevant to both human and canine
disease. Attempts at restoring vision in dogs and human
by gene therapy have been made, providing optimism
regarding potential for recovery of functional vision [36-
41]. Uncovering the genetic basis of the cone-rod dystro-
phy in the SWHD may contribute to finding new gene
therapy treatments.
The present work has excluded a number of genes as a
cause of crd in the SWHD. Research in human and ani-
mals continuously identifies new genes that may be asso-
ciated with crd. In addition to continued studies of a few
specific candidate genes, future research will focus on a
whole genome scan by linkage studies with polymorphic
markers [42] or by SNP-array typing [43]. The develop-
ment of the canine genotyping array of ~27000 SNPs
show that genome-wide association mapping of mende-
lian traits in dog breeds can be achieved with only ~20
dogs [44]. The use of SNP array technology, followed by
fine mapping based on microsatellites and regional gene
studies may be the best method to elucidate which gene is
involved in this disease.
Conclusion
The genes involved in cone degeneration, CNGB3,
CNGA3 and GNAT2, and the genes involved in cone-rod
dystrophy,  ABCA4,  RDH5,  Cord8,  Cord9,  RPGRIP1,
GUCY2D and CRX, were all excluded from being involved
in the cone-rod dystrophy described in this family of
SWHD. The study provides a number of genetic markers
for use in other studies. Further work, based on a whole
genome association study will be performed to identify
the mutation involved in the disease.
The informative resource family, consisting of offspring from a single affected male Figure 1
The informative resource family, consisting of offspring from a single affected male. The numbers below each indi-
vidual represent ABCA4 genotypes, and clearly shows the free recombination of marker-alleles compared to disease in the 
family.BMC Veterinary Research 2008, 4:23 http://www.biomedcentral.com/1746-6148/4/23
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Methods
Animals
Day blindness was diagnosed in two wire haired dachs-
hund littermates, one male and one female, in a litter of
four. The parents were phenotypically normal. The male
was bred to two unrelated crossbred dogs with no history
of previous eye disease and the dogs in the F1 generation
were unaffected. A purpose-bred colony was established
through back-crossing the male with his daughters, pro-
ducing both affected and unaffected offspring. The retinal
changes were always bilaterally symmetrical and the ini-
tial onset was observed from 10 months to 3 years of age.
A complete retinal atrophy was evident within the age of
5–6 years.
Clinical diagnosis
To evaluate vision, all dogs were subjected to behavioral
testing (maze test), examination of pupillary light reflexes
(PLRs), indirect ophthalmoscopy and bilateral full-field
electroretinography (ERG). Light microscopy, electron
microscopy and immunohistochemistry were carried out
in 22 selected cases at ages 5–304 weeks, in order to con-
firm the diagnoses [23].
All procedures used in this study adhered to the guidelines
of the Norwegian Animal Research Authority (For-
søksdyrutvalget) and to the Association for Research in
Vision and Ophthalmology's "Statement for the use of
Animals in Ophthalmic Vision and Research".
Samples
Blood samples were collected into EDTA-coated tubes
from all the related dogs in the day blind colony and from
two non-affected, unrelated dogs. Genomic DNA was iso-
lated from the blood samples using DNeasy Tissue kit
(Qiagen, GmbH, Germany).
The collected DNA samples were subjected to candidate
gene screening. All the ten loci were typed by polymorphic
markers at these loci in five informative dachshund fami-
lies comprising 43 dogs -7 parents and 36 offspring (Fig-
ure 1), to detect recombinants between each of the loci
and the disease.
Study of marker-disease segregation in the resource family
Genotyping of CNGB3 was done with two closely linked
markers, FH2772 [45] and c29.002 [46], embracing the
Table 3: Primers for amplification of the microsatellites at the exact position of the candidate gene loci
Microsatellite Forward primer (5'-3') Reverse primer (5'-3') Size of PCR-
product (bp)
Nucleotide 
repeat
Location (bp) Accession 
number
CNGB3-FH2772 CCCAAAGCACATCCTAA
TTC
GGAGTCTGCTTCTCCCT
TTC
168 di Chr29:35405042-35405217 UniSTS 263646
CNGB3-C29.002 TATTAAATCCCAGTCACC
ACCC
AGGTCCCAGACCGAGTC
C
208 di Chr29:36423257-36423471 UniSTS 262830
CNGA3-GT19 CCTCCCACTCTCCCCTC
TAC
CCAGGGGAGCTTTTACA
ACA
337 di Chr10:47307640-47307977 BV729091
CNGA3-GT20 GCAAGCAGTCCCGATTT
TTA
TCAGCTTTGGTCATGCA
CTC
304 di Chr10:47283009-47283313 BV729076
GNAT2-GAAA16 CCCATGCTTGGTTTAATG
CT
GACTGTCCTGCCTTCCA
TGT
350 tetra Chr6:45194834-45195184 BV729077
GNAT2-CTT22 CAGCTGGATTCTTCCCA
TGA
GCCCAAATTGCAAATCC
TTA
273 tri Chr6:45461591-45461864 BV729078
ABCA4-FH2370 CCTGAAAAATAGCTAGA
TGATGG
GTCTTTACCTGCCTATAT
AGCTGC
380 tetra Chr6:58367514-58367919 UniSTS 263571
ABCA4-TTTC16m GGAATCAGTGGACTCAT
CCAA
GGGGATTGGACAGTGGT
AGA
238 tetra Chr6:58046419-58046656 BV729079
RDH5-TAGA10 GAAGATGACGATGATGA
TGAAGA
GCTGAAGGTAGACGCTG
GAC
286 tetra Chr10:3068645-3068931 BV729080
RDH5-GAAA16 CCCTGCTGTGAGGAGTC
AGT
AGCCAGATGCAGGACTT
GAT
209 tetra Chr10:3002063-3002276 BV729081
CORD8-FMO5-GAAA12 CCACAAGTTGGGGTTTC
AAG
CCCCTCCTCTCTCTCTTT
CC
204 tetra Chr9:60070458-60070662 BV729082
CORD8-FMO5-TTTA10 CCCAGGTGTCCCTATTTT
CC
GCTCACTGGGGAGTCTG
CT
175 tetra Chr9:60654305-60654480 BV729083
CORD9-RP1-ATm22 CACTGGATGCACACAGA
TCC
GGTCCTTGAGAAGGAAG
CTG
296 di Chr29:9128657-9128953 BV729084
CORD9-RP1-TTTC21m TCCAGTAGGCGTCCTCT
GAC
AGTCAATGGAGCCTGCA
ACT
410 tetra Chr29:9011174-9011583 BV729085
RPGRIP1-GAAA26 TGTTACCTGTTCCAAAGT
TGTTTT
AGTTACAGCCATGGGAA
TGC
475 tetra Chr15:21287275-21287750 BV729086
GUCY2D-TTCC15 ACAATGGGCACATCTGT
TGA
TTCTCCCTCTGCCTGTG
TCT
405 tetra Chr5:35459311-35459716 BV729089
GUCY2D-GAAA17 CCCCTCTTCTCCACTCT
CCT
TCATATTCTTGCCCCAG
TCC
444 tetra Chr5:35514793-35515246 BV729090
CRX-GAAA15m TGGTCTCACATTCCCACT
GA
AGAAGTGGCAGAGCACA
GGT
438 tetra Chr1:111096908-111097346 BV729087
CRX-GT21 ACCAGAACCAAAGGCAG
ATG
TCAGGGTTGGAGTTTTG
AGC
427 di Chr1:111076912-111077339 BV729088BMC Veterinary Research 2008, 4:23 http://www.biomedcentral.com/1746-6148/4/23
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gene (530 Kb and 350 Kb distance respectively). Markers
for genotyping of CNGA3, GNAT2 ABCA4, RDH5, CRX,
GUCY2D  and  RPGRIP1  were identified by searching a
sequence of about 200,000 bp, including the gene(s)
(gene +/- ~100 000 bp), for various microsatellite
motives. FH2370, a marker closely linked to ABCA4 [46]
was also genotyped. For the loci CORD8 and CORD9, 200
000 basepairs surrounding genes at the site of the two loci,
respectively FM05 and RP1, were used to identify poly-
morphic markers. Tetra- and dinucleotide repeat micros-
atellites with more than ten and nineteen repeats,
respectively, were selected. Primers for amplification of
selected microsatellites were designed using primer3 [47]
(See Table 3). One primer in each pair was labelled with
fluorescein for automated detection in an automated frag-
ment analyzer, ABI3100 Genetic Analyser.
PCR amplification reactions were performed using 83 μM
of each primer in a 15 μl reaction containing 1.5 μl DNA
prepared as described above, 1× PCR buffer containing
1.5 mM MgCl2, 83 μM each of dATP, dCTP, dGTP and
dTTP, and 0,33 units Taq DNA polymerase (Qiagen).
After an initial denaturation at 95°C for 2 min and 30 sec,
samples were amplified for 28 cycles at 95°C for 30 sec,
58°C for 40 sec and 72°C for 50 sec, followed by a final
extension of 72°C for 5 min and 30 sec. The sizes of the
alleles were estimated with an automated sequencer (ABI
PRISM® 3100 Genetic Analyzer, Applied Biosystems, Fos-
ter City, CA, U.S.A.) with software for fragment analysis.
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